Featured Topics Featured Topics

Annual General Meeting

  • 2010 Annual General Meeting. More.

Annual Report

  • Elan 2009 Annual Report. More.
Marketed Drugs Marketed Drugs
Tysabri (natalizumab)
Ongoing Clinical Trials Ongoing Clinical Trials

Alzheimer’s Disease

  • ELND005, Phase II Studies. More.  

Crohn’s Disease

  • TYSABRI INFORM Study. More.
Product Pipeline Product Pipeline
Chart

BioNeurology
products and pipeline.
View.

Recent News Recent News

08/30/2010: Elan Corporation, plc, Announces Commencement of Asset Sale Offer to Purchase up to $186,000,000 of 8 7/8% Senior Fixed Rate Notes Due 2013 and Floating Rate Notes Due 2013 More.

08/24/2010: Preliminary Data in Support of Investigational Anti-JCV Antibody Assay Published in the Annals of Neurology More.